A novel, cheap and easy preparing selective medium for isolation of Pythium species

Sahar A Moharam1, Amna M Sadek1, Hani M A Abdelzaher2

  • 1Department of Botany and Microbiology, Faculty of Science, Minia University, El-Minia, 61519, Egypt.

AMB Express
|October 13, 2025
PubMed

Insights

A new, cost-effective selective medium, FANS (Fluconazole + Ampicillin + Nystatin + Sulbactam), simplifies isolating Pythium and Globisporangium. This method enhances Oomycota research by overcoming contamination issues and reducing expenses for global scientists.

Area of Science:

  • Microbiology
  • Mycology
  • Plant Pathology

Background:

  • Isolation of Pythium and Globisporangium (Oomycota) is challenging due to microbial contamination.
  • Existing selective media (VP3, NARM, NARF) are expensive and pose safety concerns.

Purpose of the Study:

  • To develop a novel, economical, and safe selective medium for isolating Pythium and Globisporangium species.
  • To evaluate the efficacy of the new medium against existing methods.

Main Methods:

  • A new selective medium, FANS (Fluconazole + Ampicillin + Nystatin + Sulbactam), was formulated using inexpensive pharmaceutical antibiotics.
  • The FANS medium was tested for its ability to promote growth of Pythium and Globisporangium while inhibiting contaminants.
  • Comparative analysis of FANS against VP3, NARM, and NARF was performed based on mycelial growth, zoospore, and oospore production.

Main Results:

  • The FANS medium effectively isolated Pythium and Globisporangium, completely inhibiting bacterial and fungal contaminants.
  • FANS demonstrated superior performance in promoting mycelial growth, zoospore, and oospore production compared to NARM, NARF, and VP3.
  • The FANS medium proved to be a safe and cost-effective alternative for Oomycota isolation.

Conclusions:

  • The FANS selective medium offers a simplified, safer, and more affordable method for Pythium and Globisporangium isolation.
  • This development is particularly beneficial for researchers in developing and low-income countries.
  • FANS enhances the accessibility and efficiency of Oomycota research globally.